Dan‐Qin Sun

1.4k total citations · 1 hit paper
33 papers, 848 citations indexed

About

Dan‐Qin Sun is a scholar working on Epidemiology, Hepatology and Nephrology. According to data from OpenAlex, Dan‐Qin Sun has authored 33 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Nephrology. Recurrent topics in Dan‐Qin Sun's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (12 papers) and Diet, Metabolism, and Disease (4 papers). Dan‐Qin Sun is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (12 papers) and Diet, Metabolism, and Disease (4 papers). Dan‐Qin Sun collaborates with scholars based in China, United Kingdom and Italy. Dan‐Qin Sun's co-authors include Ming‐Hua Zheng, Giovanni Targher, Christopher D. Byrne, Weichun He, Chunsun Dai, Junwei Yang, Ting Cai, Ying Duan, Kenneth I. Zheng and Weijie Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Dan‐Qin Sun

31 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MAFLD and risk of CKD

2020 209 citations Dan‐Qin Sun, Yan Jin et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan‐Qin Sun China	14	525	225	211	194	138	33	848
Baihui Xu China	19	378 0.7×	366 1.6×	88 0.4×	159 0.8×	80 0.6×	31	985
Muammer Kara Türkiye	15	425 0.8×	152 0.7×	129 0.6×	79 0.4×	56 0.4×	37	654
Valter Donadon Italy	20	618 1.2×	324 1.4×	480 2.3×	452 2.3×	88 0.6×	29	1.3k
Tomomi Kogiso Japan	19	731 1.4×	253 1.1×	448 2.1×	195 1.0×	27 0.2×	74	1.0k
Andreas Stadlmayr Austria	17	688 1.3×	251 1.1×	188 0.9×	156 0.8×	21 0.2×	31	1.2k
Takuya Wakamatsu Japan	7	322 0.6×	228 1.0×	81 0.4×	86 0.4×	120 0.9×	10	526
Maria Antonella Burza Sweden	15	665 1.3×	401 1.8×	240 1.1×	106 0.5×	26 0.2×	21	985
L. Bertolini Italy	11	784 1.5×	521 2.3×	224 1.1×	59 0.3×	44 0.3×	14	1.1k
Yeşim Özen Alahdab Türkiye	13	348 0.7×	105 0.5×	125 0.6×	46 0.2×	40 0.3×	40	567
Tomohiro Kaneko Japan	16	229 0.4×	91 0.4×	53 0.3×	202 1.0×	299 2.2×	61	853

Countries citing papers authored by Dan‐Qin Sun

Since Specialization

Citations

This map shows the geographic impact of Dan‐Qin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐Qin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐Qin Sun more than expected).

Fields of papers citing papers by Dan‐Qin Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐Qin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐Qin Sun. The network helps show where Dan‐Qin Sun may publish in the future.

Co-authorship network of co-authors of Dan‐Qin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐Qin Sun. A scholar is included among the top collaborators of Dan‐Qin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐Qin Sun. Dan‐Qin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Dan‐Qin, Jiahui Zhang, Hong Tang, et al.. (2025). Oxidized-LDL aggravates renal injury via tubular cuproptosis. Cellular Signalling. 132. 111839–111839. 2 indexed citations

Sun, Dan‐Qin, Fan Yang, Xiaowei Zheng, et al.. (2025). Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children. Frontiers in Endocrinology. 16. 1505050–1505050.

Zhang, Xinlei, Yeqing Gu, Jing Zhao, et al.. (2025). Associations between skeletal muscle strength and chronic kidney disease in patients with MASLD. Communications Medicine. 5(1). 118–118. 1 indexed citations

Ding, Liang, Pingli Wang, Jianzhen Shan, et al.. (2024). EP.08D.09 Efficacy and Safety of Neoadjuvant Tislelizumab Plus Chemotherapy for the Treatment of Non-Small Cell Lung Cancer: a Pooled Analysis. Journal of Thoracic Oncology. 19(10). S571–S572.

Sun, Dan‐Qin, Jiaqi Shen, Yangyang Li, et al.. (2024). FRI-267 Regional fibrosis progression analysed by digital pathology with artificial intelligence is associated with renal dysfunction. Journal of Hepatology. 80. S488–S489. 1 indexed citations

Tang, Liang‐Jie, Dan‐Qin Sun, Sherlot Juan Song, et al.. (2024). Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver International. 44(5). 1129–1141. 4 indexed citations

Chen, Wen‐Ying, Jiahui Zhang, Lili Chen, et al.. (2024). Bioactive metabolites: A clue to the link between MASLD and CKD?. Clinical and Molecular Hepatology. 31(1). 56–73. 3 indexed citations

Sun, Dan‐Qin, Yuan Qin, Tianyu Zheng, et al.. (2024). Development and application of an amplified luminescent proximity homogeneous assay-linked immunosorbent assay for the accurate quantification of kidney injury molecule-1. Frontiers in Molecular Biosciences. 10. 1280681–1280681. 2 indexed citations

Zhao, Jing, Lu Liu, Yingying Cao, et al.. (2024). MAFLD as part of systemic metabolic dysregulation. Hepatology International. 18(S2). 834–847. 20 indexed citations

10.

Feng, Gong, Xiaoxun Zhang, Liangjun Zhang, et al.. (2023). Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages. Liver International. 43(6). 1234–1246. 5 indexed citations

11.

Sun, Dan‐Qin, Ling Jiang, Liang‐Jie Tang, et al.. (2023). Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 57(8). 872–885. 25 indexed citations

12.

Zhou, Jianghua, Dan‐Qin Sun, Giovanni Targher, et al.. (2023). Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 1(1). e100005–e100005. 13 indexed citations

13.

Sun, Dan‐Qin, Shiliang Zhang, Yan Lü, et al.. (2023). Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling. Molecular Metabolism. 79. 101841–101841. 7 indexed citations

14.

Liu, Fengping, Xuefang Xu, Chao Lin, et al.. (2021). Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains. Frontiers in Immunology. 12. 609700–609700. 29 indexed citations

15.

Sun, Dan‐Qin, Ting-Yao Wang, Kenneth I. Zheng, et al.. (2021). The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. Nutrition Metabolism and Cardiovascular Diseases. 31(6). 1822–1831. 12 indexed citations

16.

Sun, Dan‐Qin, Yan Jin, Ting-Yao Wang, et al.. (2020). MAFLD and risk of CKD. Metabolism. 115. 154433–154433. 209 indexed citations breakdown →

17.

Sun, Dan‐Qin, Haluk Tarık Kani, Jianjing Yang, et al.. (2019). Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD. Diabetes & Metabolism. 46(4). 288–295. 22 indexed citations

18.

Sun, Dan‐Qin, Lai Zhang, Chenfei Zheng, et al.. (2019). Metabolic Acidosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury. Journal of Clinical and Translational Hepatology. 7(X). 1–10. 9 indexed citations

19.

Sun, Dan‐Qin, Shengjie Wu, Wen‐Yue Liu, et al.. (2016). Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. BMJ Open. 6(12). e013781–e013781. 53 indexed citations

20.

Sun, Dan‐Qin, Wen‐Yue Liu, Shengjie Wu, et al.. (2015). Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. Oncotarget. 7(5). 5728–5737. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact